Jump to content

Flemming Ørnskov

From Wikipedia, the free encyclopedia
Flemming Ørnskov
Born1957 or 1958 (age 65–66)[1]
Alma materUniversity of Copenhagen
Harvard University
Occupation(s)CEO, Galderma

Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma[2] since October 2019.

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.[3] He previously worked for Bayer, Bausch & Lomb and Novartis.[2]

He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.[4][5]

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[1]

Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017.[6][7] He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.[8]


Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review[9]

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech[10]


  1. ^ a b "Executive Profile: Flemming Ornskov". Bloomberg. Retrieved 4 September 2017.
  2. ^ a b Liu, Angus (October 8, 2019). "Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout". Fiercepharma.
  3. ^ "Shire chief finds right prescription for growth". The Telegraph. 29 December 2013. Retrieved 20 March 2014.
  4. ^ "Conseil d'administration : Waters". www.waters.com. Retrieved 2021-04-01.
  5. ^ "Waters Corporation Elects Flemming Ornskov to Board of Directors". Business Wire. June 2, 2017. Retrieved June 21, 2024.
  6. ^ Swetha Gopinath and Allegra Catelli (2024-03-22). "Galderma Surges in Debut, Bolstering Europe IPO Recovery". www.bloomberg.com. Retrieved 2024-06-14.
  7. ^ "GALDERMA STOCK SURGES IN DEBUT ON SWISS STOCK EXCHANGE SIX". Beauty Matter. 2024-03-22. Retrieved 2024-06-14.
  8. ^ "EQT's Galderma Seeks to Raise $2.3 Billion in Swiss Listing". The Business of Fashion. 2024-03-07. Retrieved 2024-06-14.
  9. ^ "The 'best-performing' CEO in the world is a pharma chief". BioPharma Dive. Retrieved 2021-04-01.
  10. ^ "The 25 most influential people in biopharma today - 2013". FierceBiotech. Retrieved 2021-04-01.